Profile avatar
esbwenge.bsky.social
MD, PhD – Infectious Diseases Epidemiologist, Johns Hopkins University, and Center for Tropical Diseases and Global health, Bukavu, DR Congo. Interested in cholera, mpox, outbreaks, vaccines, and Barcelona football club.
13 posts 567 followers 109 following
Regular Contributor
Posts 21 Comments 6

In this second paper, clade Ib mpox outbreak in Uvira primarily affected children under 15 years (63.7%), with limited reported sexual transmission. Occupational healthcare and workplace exposures were rare. The overall case fatality ratio was 0.7%, but high among HIV-positive and infants < 1 yr.

submitted 1 day ago • 1 comment

Mpox Clade Ib incubation periods are longer than previous MPXV estimates and vary by exposure route, with shorter periods for sexual transmission. These differences suggest the need to revise post-exposure monitoring guidelines. doi.org/10.1101/2025...

submitted 1 day ago • 0 comments

New correspondence in The Lancet Infectious Diseases Disseminated mpox in an immunocompromised patient in DR Congo: a call for a shift from disease-focused to person-centred outbreak response www.thelancet.com/journals/lan...

submitted 36 days ago • 0 comments

"Although reactive vertical approaches can provide rapid responses to outbreaks, they often fail to strengthen broader health systems, leaving countries ill-prepared for future crises and jeopardising progress toward universal health coverage and pandemic resilience www.thelancet.com/journals/lan...

submitted 36 days ago • 0 comments

This raises an important point. The U.S. withdrawal from WHO would undoubtedly disrupt critical health programs and initiatives, potentially causing significant harm, especially in vulnerable regions. www.bbc.com/news/article...

submitted 38 days ago • 1 comment

Whether it’s Ebola, cholera, or mpox, the same issues persist—narrowly focused vertical programs driven by donor priorities. In an upcoming piece, we reflect on this challenge in the context of the current mpox outbreak in eastern DR Congo.

submitted 40 days ago • 0 comments

From HiV to Ebola to Covid and mpox, inequities in access is a defining feature Grateful to @craigspencer.bsky.social for his advocacy www.nejm.org/doi/full/10....

submitted 41 days ago • 1 comment

Who are you “performing” for? A book review and personal reflections on: The Foreign Gaze – Essays on Global Health by @seyeabimbola.bsky.social katribertram.wordpress.com/2025/01/06/w...

submitted 53 days ago • 0 comments

submitted 63 days ago • 0 comments

The root causes of measles mortality and recent headline grabbing malaria outbreak in DRC are the same: poverty, access, infrastructure. All are legacies of oppressive history.

submitted 72 days ago • 1 comment

If the unknown disease X in the DRC is malaria... its concernig that in 2024, there are still areas on earth unable to diagnose malaria. How can we discuss advancements like genomics surveillance when we have yet to address the basics of infectious diseases surveillance in DR Congo?

submitted 79 days ago • 1 comment

This doctor raised the alarm about a deadly mpox outbreak that went global Placide Mbala is part of Nature’s 10, a list of people who shaped science in 202 www.nature.com/articles/d41...

submitted 81 days ago • 2 comments

The DRC spends just $22 per person annually on health care. A single Mpox test costs $20. This is outrageous. Poorer countries shouldn't have to pay heightened test prices just so big pharma can make a bigger profit. Drop the price now.

submitted 90 days ago • 1 comment

Very happy to see this important collaborative work out on preprint now detailing clinical and epidemiological considerations for Clade Ib mpox www.medrxiv.org/content/10.1...

submitted 101 days ago • 2 comments

If you are interested in #emergingviruses, new #vaccines & #publichealth, save the date for this event! April 7-9, 2025 in Geneva, co-hosted by our Centre for Emerging Viral Diseases & the Centre of Vaccinology of the University of Geneva & University Hospitals of Geneva! Superb speakers list!

submitted 98 days ago • 3 comments

So here is a starter pack of African scientists and researchers across disciplines. It will continue to grow as I find more people and more migrate to this platform but gotta start somewhere 😊. go.bsky.app/GixA4xP

submitted 99 days ago • 34 comments

Hi Bluesky! I’m an infectious diseases doctor, public health practitioner, and academic. I post about public health, social determinants of health and the places I work, have lived in, and travel to especially: 🇭🇹 🇺🇬 🇺🇸🇮🇪.

submitted 103 days ago • 2 comments

“He stopped in the middle of a lecture to announce, ‘ONE OF YOU WILL BETRAY ME,’ right after I had told him that I was switching advisors.”

submitted 334 days ago • 3 comments

We can't avoid models - even insights from 'raw data' require assumptions... New post: kucharski.substack.com/p/we-cant-av...

submitted 402 days ago • 0 comments

Excited to see our working out in The Lancet Infectious Diseases on the effectiveness of one dose of oral cholera vaccine (OCV) in DR Congo. One dose of OCV protects against clinical cholera for up to 24-36 mo www.thelancet.com/journals/lan... with @justinlessler.bsky.social @andrewazman.bsky.social

submitted 406 days ago • 0 comments

We are recruiting for Research Assistant Professor positions at UNC to work on projects aimed at making epidemic projections and analytics more accurate and more relevant to those who need them most. Consider applying to join our team! unc.peopleadmin.com/postings/270...

submitted 452 days ago • 0 comments